Novo Nordisk eyes IPO for its IT subsidiary, taps new CFO to lead review

Tracy Staton

Strategic reviews, sales and spinoffs are trendy in Big Pharma these days. Now, the Danish drugmaker has joined the bunch. Novo says it's weighing an initial public offering for its IT , NNIT, and has hired a new CFO for the unit to handle the .

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS